These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6422042)

  • 41. Isoxazolidine-3,5-diones as lens aldose reductase inhibitors.
    Richon AB; Maragoudakis ME; Wasvary JS
    J Med Chem; 1982 Jun; 25(6):745-7. PubMed ID: 6808134
    [No Abstract]   [Full Text] [Related]  

  • 42. [Diabetic changes in pupillary reactions and iris histology. No. 3. The role of aldose reductase inhibitor to iridal vessel hyperpermeability of galactose-fed rats].
    Kador PF; Kinoshita JH; Terubayashi H; Akagi Y; Kador PF; Kinoshita JH
    Nippon Ganka Gakkai Zasshi; 1988 Oct; 92(10):1577-81. PubMed ID: 3145680
    [No Abstract]   [Full Text] [Related]  

  • 43. Chemical and pharmaceutical studies on medicinal plants in Paraguay. I. Isolation and identification of lens aldose reductase inhibitor from "tapecué," Acanthospermum australe O.K.
    Shimizu M; Horie S; Arisawa M; Hayashi T; Suzuki S; Yoshizaki M; Kawasaki M; Terashima S; Tsuji H; Wada S
    Chem Pharm Bull (Tokyo); 1987 Mar; 35(3):1234-7. PubMed ID: 3111729
    [No Abstract]   [Full Text] [Related]  

  • 44. Structure-activity correlation of flavonoids for inhibition of bovine lens aldose reductase.
    Iinuma M; Tanaka T; Mizuno M; Katsuzaki T; Ogawa H
    Chem Pharm Bull (Tokyo); 1989 Jul; 37(7):1813-5. PubMed ID: 2509087
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of aldose reductase inhibition on erythrocyte polyols and galactitol accumulation in diabetic patients.
    Airey CM; Price DE; Kemp JV; Perkins CM; Wales JK
    Diabet Med; 1989 Dec; 6(9):804-8. PubMed ID: 2533041
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention of basement membrane thickening in retinal capillaries by a novel inhibitor of aldose reductase, tolrestat.
    Robison WG; Kador PF; Akagi Y; Kinoshita JH; Gonzalez R; Dvornik D
    Diabetes; 1986 Mar; 35(3):295-9. PubMed ID: 3081393
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and biological evaluation of irreversible inhibitors of aldose reductase.
    Ares JJ; Kador PF; Miller DD
    J Med Chem; 1986 Nov; 29(11):2384-9. PubMed ID: 3097318
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A; Cruz E
    Diabetes; 1985 Jan; 34(1):15-21. PubMed ID: 3917257
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Raman spectroscopic study of the effect of aldose reductase inhibitor on experimental diabetic cataract.
    Nozawa H; Yaginuma T; Mizuno A
    Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):194-201. PubMed ID: 3133929
    [No Abstract]   [Full Text] [Related]  

  • 50. Cannabis sativa L. (marijuana) IX: Lens aldose reductase inhibitory activity of marijuana flavone C-glycosides.
    Segelman AB; Segelman FP; Varma SD; Wagner H; Seligmann O
    J Pharm Sci; 1977 Sep; 66(9):1358-9. PubMed ID: 409835
    [No Abstract]   [Full Text] [Related]  

  • 51. [Substrate specificity and inhibition by various compounds of aldose reductase II from rabbit lens].
    Tanimoto T; Fukuda H; Kawamura J
    Yakugaku Zasshi; 1984 Jun; 104(6):631-4. PubMed ID: 6438300
    [No Abstract]   [Full Text] [Related]  

  • 52. Inhibition of lens and cataract aldose reductase by protein-bound anti-rheumatic drugs: salicylate, indomethacin, oxyphenbutazone, sulindac.
    Sharma YR; Cotlier E
    Exp Eye Res; 1982 Jul; 35(1):21-7. PubMed ID: 6807700
    [No Abstract]   [Full Text] [Related]  

  • 53. Design and synthesis of 2-(arylamino)-4(3H)-quinazolinones as novel inhibitors of rat lens aldose reductase.
    DeRuiter J; Brubaker AN; Millen J; Riley TN
    J Med Chem; 1986 May; 29(5):627-9. PubMed ID: 3084783
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prevention of rat galactose cataract with topical aldose reductase inhibitor, E-1008].
    Tasaka H; Akagi Y; Yoshikawa T; Ikebe H; Takahashi Y; Chamoto K; Miyamoto Y; Terubayashi H
    Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):246-53. PubMed ID: 3111200
    [No Abstract]   [Full Text] [Related]  

  • 55. Galactose feeding causes glomerular hyperperfusion: prevention by aldose reductase inhibition.
    Bank N; Coco M; Aynedjian HS
    Am J Physiol; 1989 Jun; 256(6 Pt 2):F994-9. PubMed ID: 2500030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. AL-1576, an aldose reductase inhibitor (ARI), did not prevent the decrease of norepinephrine turnover in diabetic rats.
    Yen TT; Fuller RW; Broderick CL; Hemrick-Luecke SK; Perry KW
    Res Commun Chem Pathol Pharmacol; 1988 Aug; 61(2):257-60. PubMed ID: 3141993
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of aldose reductases from rabbit lens by oxazole derivatives.
    Tanimoto T; Fukuda H; Kawamura J; Nakao M; Shimada U; Yamada A; Tanaka C
    Chem Pharm Bull (Tokyo); 1984 Mar; 32(3):1032-9. PubMed ID: 6430576
    [No Abstract]   [Full Text] [Related]  

  • 58. Pharmacophor requirements of the aldose reductase inhibitor site.
    Kador PF; Sharpless NE
    Mol Pharmacol; 1983 Nov; 24(3):521-31. PubMed ID: 6415401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Studies on lens-aldose-reductase inhibitor in medicinal plants. II. Active constituents of Monochasma savatierii Franch. et Maxim.
    Kohda H; Tanaka S; Yamaoka Y; Yahara S; Nohara T; Tanimoto T; Tanaka A
    Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3153-4. PubMed ID: 2517245
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prolonged fructose feeding and aldose reductase inhibition: effect on the polyol pathway in kidneys of normal rats.
    Bellomo G; Comstock JP; Wen D; Hazelwood RL
    Proc Soc Exp Biol Med; 1987 Dec; 186(3):348-54. PubMed ID: 3122222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.